- Oops!Something went wrong.Please try again later.
SINGAPORE — Chinese vaccine maker Sinovac has recently submitted the required safety data for its CoronaVac COVID-19 vaccine as part of its application for the Pandemic Special Access Route approval, Health Minister Ong Ye Kung said in Parliament on Monday (26 July).
The data on the efficacy of the Sinovac vaccine against the Delta variant is still building up, the co-chair of the multi-ministry taskforce on COVID-19 said.
Delivering his Ministerial Statement, Ong said the Health Sciences Authority and the Expert Committee are going through the various data regarding the vaccine.
“When the evidence justifies it, we will certainly want to extend the concessions to individuals who have received the Sinovac or other vaccines which may qualify.”
Ong, who was delivering his Ministerial Statement, said as of Sunday, about 72,000 persons have received at least one dose of the Sinovac vaccine, and about 17,000 persons have received their second doses.
Amongst those who have taken the vaccine, 28 per cent are Singapore citizens, and they are mostly young, according to Ong. For those who have taken the Sinovac vaccine and are seniors above 60 years old, less than 10 per cent are Singaporeans.
If the supply of 200,000 doses which the government has procured is insufficient to cater to the demand, private clinics can bring in additional supply under the Special Access Route, he added.
Stay in the know on-the-go: Join Yahoo Singapore's Telegram channel at http://t.me/YahooSingapore